Clinical Trials on Chronic Renal Failure Requiring Hemodialysis in United States

Total 2253 results

Baxter Healthcare Corporation
University of Louisville; Gambro Renal Products, Inc.

Completed

Comparative Effects Of Dialysate Flow Rate And Membrane Packing On The Performance Of Dialyzers Used For Hemodialysis

Chronic Kidney Disease | Chronic Renal Disease

United States
Vidasym, Inc.

Completed

A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of VS 105

Chronic-kidney Disease Stage 5D on Stable Hemodialysis

United States
Brigham and Women's Hospital

Recruiting

Advance Care Planning in the Emergency Department

Chronic Obstructive Pulmonary Disease | Metastatic Cancer | Congestive Heart Failure | Chronic Kidney Disease Requiring Chronic Dialysis

United States
Affymax

Terminated

Extension Study to Evaluate Safety and Tolerability of Peginesatide for Long-Term Treatment of Anemia in Participants With CKD (EU)

Anemia | Chronic Kidney Disease | Chronic Renal Failure

Bulgaria, Romania, Poland, United Kingdom
Vanderbilt University Medical Center

Completed

Mitochondria and Chronic Kidney Disease (MitoCKD)

Mitochondrial Diseases | Hemodialysis-Induced Symptom

United States
University of Maryland, Baltimore
Living Legacy Foundation

Completed

Novel Strategies for Innovating Deceased Donor Procurement

Kidney Failure, Chronic

United States
FDA Office of Orphan Products Development
Vanderbilt University

Completed

Randomized Study of Recombinant Human Growth Hormone in Patients on Chronic Hemodialysis or Peritoneal Dialysis

Kidney Failure, Chronic

United States
Affymax
Takeda

Completed

Safety and Efficacy of Peginesatide for the Treatment of Anemia in Participants With Chronic Renal Failure Not on Dialysis (PEARL 2)

Anemia | Chronic Kidney Disease | Chronic Renal Failure

United States, Bulgaria, United Kingdom, Czech Republic, Germany, Hungary, Italy, Poland, Puerto Rico, Romania
Affymax
Takeda

Completed

Safety & Efficacy of Peginesatide for Maintenance Treatment of Anemia in Participants With Chronic Kidney Disease on Hemodialysis (EMERALD 2)

Anemia | Chronic Kidney Disease | Chronic Renal Failure

United States, Bulgaria, Romania, United Kingdom, Italy, Poland, France, Germany, Spain
Medtronic Vascular

Completed

Renal Denervation in End Stage Renal Disease Patients With Refractory Hypertension

Kidney Failure, Chronic | Renal Dialysis

United States
University of Toledo Health Science Campus

Withdrawn

High Pressure Balloon vs Cutting Balloon

End Stage Renal Failure on Dialysis

United States
Massachusetts General Hospital

Withdrawn

Direct-acting Antiviral Therapy to Prevent HCV Infection for HCV Positive Donor to HCV Negative Recipient Kidney Transplant

Hepatitis C | Renal Failure Chronic

United States
University of Cincinnati
National Institutes of Health (NIH)

Completed

Nutrient Levels Alter Transplant Outcome

Chronic Renal Disease

United States
Hansa Biopharma AB

Completed

A Phase II Study to Evaluate the Efficacy of IdeS to Desensitize Transplant Patients With a Positive Crossmatch Test (Highdes)

Kidney Failure, Chronic

United States, Sweden, France
Cipla USA Inc.

Completed

Plazomicin Study in ESRD Patients Receiving IHD

End Stage Renal Disease

United States
Massachusetts General Hospital

Completed

Renal Allograft Tolerance Through Mixed Chimerism

End Stage Renal Disease

United States
National Institute of Allergy and Infectious Diseases...

Completed

Prevention of Kidney Transplant Rejection

End-Stage Renal Disease | Chronic Allograft Nephropathy

United States
NxStage Medical

Completed

Comparison of Nocturnal Hemodialysis (NHD) and Short Daily Hemodialysis (DHD) With the NxStage® System One™

Kidney Failure, Chronic | End-Stage Renal Disease

United States
Imperial College Healthcare NHS Trust

Completed

Standard Versus Prolonged-release Tacrolimus Monotherapy After Alemtuzumab Induction in Kidney Transplantation (TAESR)

Graft Rejection | End-stage Renal Failure

United Kingdom
Speedel Pharma Ltd.
Quintiles, Inc.

Completed

A Clinical Study to Assess the Safety of PEG-Hirudin (SPP200) Compared to Heparin in Patients Who Are on Haemodialysis

Chronic Kidney Failure | Vascular Graft Occlusion

United States
University of Leeds
Baxter Healthcare Corporation; National Health Service, United Kingdom; Foundation... and other collaborators

Completed

Developing and Evaluating the Yorkshire Dialysis Decision Aid (YoDDA)

Chronic Kidney Failure

United Kingdom
Amy Finkelstein
Massachusetts Institute of Technology

Completed

Treatment Choice and Outcomes for ESRD: Evidence From the First Year of a Nationwide Randomized Evaluation

End Stage Renal Disease

United States
Shire

Completed

Pharmacodynamic Study of Two Lanthanum Carbonate Formulations in Healthy Adults

End Stage Renal Disease

United States
Montefiore Medical Center

Terminated

Anesthetic Technique for AV Fistulae Creation

End Stage Renal Failure on Dialysis

United States
University of Cincinnati
Astellas Pharma Inc

Completed

Pharmacokinetics of Immunosuppressants in Renal Transplant Candidates Who Have Undergone Laparoscopic Sleeve Gastrectomy

End Stage Renal Disease

United States
Chelsea Therapeutics

Withdrawn

A Multi-Center, Open-Label Study

End Stage Renal Disease | Renal Disease

United States
Affymax
Takeda

Completed

Safety & Efficacy of Peginesatide for the Treatment of Anemia in Participants With Chronic Renal Failure Not on Dialysis (PEARL 1)

Anemia | Chronic Kidney Disease | Chronic Renal Failure

United States, Puerto Rico
Hoffmann-La Roche

Completed

A Study of Obinutuzumab to Evaluate Safety and Tolerability in Hypersensitized Adult Participants With End Stage Renal Disease Awaiting Transplantation

Kidney Failure, Chronic

United States
Affymax
Takeda

Completed

Safety & Efficacy of Peginesatide for Maintenance Treatment of Anemia in Participants With Chronic Kidney Disease on Hemodialysis (EMERALD 1)

Anemia | Chronic Kidney Disease | Chronic Renal Failure

United States
National Institute of Allergy and Infectious Diseases...
Clinical Trials in Organ Transplantation

Completed

A Retrospective Multicenter Study to Determine 5-Year Clinical Outcomes in Subjects Previously Enrolled in the CTOT-01 Study

End Stage Renal Disease | Kidney Failure | Kidney Disease

United States, Canada
Mark A. Lumley
Henry Ford Health System

Completed

Family Meeting Study for End Stage Renal Disease

End-stage Renal Disease

United States
Vanderbilt University Medical Center
National Center for Complementary and Integrative Health (NCCIH)

Completed

End-Stage Renal Disease Intra-dialysis Lifestyle Education Study (END-IDLE)

End-stage Renal Disease

United States
University of Kansas Medical Center
Veloxis Pharmaceuticals

Completed

Alterations in Cognitive Function and Cerebral Blood Flow After Conversion From Immediate Release Tacrolimus to Slow Release Envarsus

End Stage Renal Disease

United States
Outset Medical

Completed

The EvAluation of TaBlo In-CLinic and In-HOme (TABLO)

End Stage Renal Disease

United States
Purdue University

Completed

Pilot Study of Taste Sensations in Patients With End-stage Renal Disease on Hemodialysis

End Stage Renal Disease

United States
FAST BioMedical

Completed

Pilot Study to Evaluate Safety, Tolerability, and Performance of the FAST PV Technology™ in Chronic Dialysis Patients

End Stage Renal Disease

United States
University of Maryland, Baltimore

Completed

Chitosan Chewing Gum Study in Dialysis Patients

End Stage Renal Disease

United States
Fresenius Medical Care North America

Completed

Acid-Base Composition With Use of hemoDialysates (ABChD)

End Stage Renal Disease

United States
Vanderbilt University

Completed

Increasing Autonomous Motivation in ESRD to Enhance Phosphate Binder Adherence

End Stage Renal Disease

United States
University of Wisconsin, Madison
Genentech, Inc.

Withdrawn

Rituximab Desensitization Therapy for Patients on the Waiting List for Kidney Transplant

End Stage Renal Disease

United States
Renal Research Institute

Completed

A Comparison of Physical Activity Levels With and Without Feedback Via Fitbit® Flex™ in Hemodialysis Patients (IAM)

End Stage Renal Disease

United States
Vanderbilt University

Completed

The Effects of Protein Supplementation and Resistance Exercise in Hemodialysis Patients

End Stage Renal Disease

United States
Vanderbilt University

Completed

The Effects of Nutrition Supplementation and Resistance Exercise During Hemodialysis

End Stage Renal Disease

United States
Baxter Healthcare Corporation
University of California, Davis; Vanderbilt University Medical Center; University... and other collaborators

Completed

Study of How the Dose of Dialysis is Affected by Dialysate Flow Rate

Chronic Kidney Disease | Chronic Renal Disease

United States
Jason Stubbs, MD
American Heart Association

Withdrawn

Impact of Rifaximin Therapy on Intestinal Byproducts in End-Stage Renal Disease

End Stage Renal Disease

United States
University of Illinois at Urbana-Champaign
Renal Research Institute

Recruiting

Dietary Sodium-Restriction (DIS) and Renal Meals (RM) for Hemodialysis (HD)(DISaRM-HD) (DISaRM-HD)

Kidney Failure, Chronic | Dietary Modification

United States
GE Healthcare

Completed

Data Collection for Next Generation Ultrasound Technology Development

Endstage Renal Disease

United States
Washington University School of Medicine

Completed

Improving Adherence in Renal Dialysis Patients Through Electronic Interventions

Endstage Renal Disease

United States
Merit Medical Systems, Inc.
CryoLife, Inc.

Completed

HeRO Graft Compared to Permanent Catheters for End Stage Renal Disease (ESRD) Patients Receiving Hemodialysis

End Stage Renal Disease (ESRD)

United States
Wake Forest University Health Sciences

Completed

A Pilot Trial of Twice-weekly Versus Thrice-weekly Hemodialysis in Patients With Incident End-stage Kidney Disease (TWOPLUS-HD)

End Stage Renal Failure on Dialysis

United States

Clinical Trials on Chronic Renal Failure Requiring Hemodialysis in United States

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in United States

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations